Peptides

[Pyr11]-beta-Amyloid (11-40) - 1 mg

384.00
Check your price
  • Cat.Number : AS-29904-1
  • Availability :
    In stock

Select specification

Quantity

A hallmark of Alzheimer's disease (AD) is the presence of beta-Amyloid in plaques in the brains of patients. N-terminally truncated pyroglutamate-modified beta-Amyloid forms such as Aß(3-40) and Aß (11- 40) have been described as major compounds in the senile plaques. Pyro-Glu modified beta-Amyloid forms are more resistant to degradation, show higher toxicity and have increased aggregation propensity compared to non-modified beta-Amyloid.

Specifications

Chemistry
Sequence one letter code
  • Pyr-VHHQKLVFFAEDVGSNKGAIIGLMVGGVV
Sequence three letter code
  • Pyr-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
CAS registry number
  • 192377-94-9
Molecular Formula
  • C143H226N38O39S
Molecular Mass/ Weight
  • 3133,7
Modification
Conjugation
  • Unconjugated
Quantity & Purity
Purity
Storage & stability
Form
  • Lyophilized
Storage Conditions
  • - 20 °C
Activity
Biomarker Target
Research Area
Sub-category Research Area
Usage
  • Research use
Source
Source / Species
  • human
Codes
Code Nacres
  • NA.26

You may also be interested in the following product(s)

Tube AggreSure Beta-Amyloid (1-40), human - 0.25 mg

AggreSure ß-Amyloid (1-40), human - 0.25 mg

Cat.Number : AS-72215
263.00 Excl. Tax
Tube of Beta-Amyloid (1-42) peptide

Beta-Amyloid (1-42)

Cat.Number : AS-20276
285.00 Excl. Tax